Angela Burge

Jan 20, 2025 | dovepress.com | Angela Burge |Narelle S. Cox |Simone Dal Corso |Arwel W Jones

Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 20 Authors Burge AT , Cox NS , Dal Corso S, Jones AW , Faqih FM, Holland AE Received 15 August 2024 Accepted for publication 19 November 2024 Published 20 January 2025 Volume 2025:20 Pages 149—158 DOI https://doi.org/10.2147/COPD.S491654 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Richard Russell Angela T Burge,1,2...

Oct 9, 2024 | err.ersjournals.com | Angela Burge |Anna Spathis |Natasha Smallwood |Anne Holland

IntroductionPeople with serious respiratory illness experience a high symptom burden, including fatigue, which is highly prevalent and has a profound impact on daily life participation and health-related quality of life (HRQoL) [1–5]. Fatigue is reported by up to 95% of people with COPD or interstitial lung disease (ILD) and 60% of people with asthma or pulmonary hypertension [1–4].

Aug 8, 2024 | erj.ersjournals.com | Melissa Chong |Anne Holland |Angela Burge

FootnotesAuthor contributions: Conceptualisation and design: N.S. Cox. Data acquisition: M. Chong, A.E. Holland, A.T. Burge, J. Perrryman and N.S. Cox. Data analysis: M. Chong and N.S. Cox. Drafting manuscript: M. Chong and N.S. Cox. Critical review of manuscript: M. Chong, A.E. Holland, A.T. Burge, J. Perrryman and N.S. Cox. Conflict of interest: The authors have no potential conflicts of interest to disclose.

Jul 26, 2024 | erj.ersjournals.com | Melissa Chong |Anne Holland |Angela Burge

FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article. Conflict of Interest: All authors have nothing to disclose. Received March 5, 2024.

Jun 28, 2024 | erj.ersjournals.com | Anne Holland |Anna Spathis |Claudia Bausewein |Angela Burge

IntroductionChronic lung diseases, such as COPD and interstitial lung disease (ILD), are among the leading causes of disability and premature death worldwide [1]. Respiratory symptoms, predominantly breathlessness and cough, are widely reported by people with serious respiratory illness and adversely impact health-related quality of life (HRQoL) [2, 3]. Breathlessness may be insufficiently recognised [4] and under-treated [5].